FGF19 and type 2 diabetes mellitus: The pathophysiology relevance between CDCA and different glucose tolerance categories is reminiscent of the results in our previous and present studies that fasting serum FGF19 levels were decreased in subjects with I-IFG and T2DM but not in I-IGT6.